Merck & Co., Inc. ( MRK) - Stock Earnings
MRK Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026 BeforeMarket | — / — | — | — / — | — |
MRK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 3.0 billion USD | 16.3 billion USD |
| 2026Q1 | -4.2 billion USD | 16.3 billion USD |
| 2026Q2 | -1.3 billion USD | 16.6 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
MRK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 365.0 million USD | 60.1 billion USD |
| 2024 | 17.1 billion USD | 64.2 billion USD |
| 2025 | 18.3 billion USD | 64.9 billion USD |
| 2026 Est. | — | — |
MRK
Price: $156.43
Dividend Yield: 2.58%
Forward Dividend Yield: 2.26%
Payout Ratio: 57.04%
Dividend Per Share: 3.40 USD
Earnings Per Share: 1.25 USD
P/E Ratio: 104.74
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 7.8 million
Ebitda: 2.3 billionMarket Capitalization: 323.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 65
DGR3: 5.49%
DGR5: 6.85%
DGR10: 6.62%
DGR20: 4.19%